Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture.
OBJECTIVE
A novel link between inflammation and acute coronary syndromes is emerging, in that infiltrating inflammatory cells may convert a clinically silent coronary plaque into a dangerous and potentially lethal plaque. The majority of acute atherothrombotic events now relate to erosion or rupture of such unstable plaques. Here we summarize the molecular mechanisms by which activated mast cells may contribute to plaque erosion or rupture.


RESULTS
In-vitro experiments have revealed a multitude of paracrine effects exerted by activated mast cells. By secreting heparin proteoglycans and chymase, activated mast cells efficiently inhibit the proliferation of smooth muscle cells in vitro, and reduce their ability to produce collagen by a transforming growth factor beta-dependent and -independent mechanism. Mast cell chymase and tryptase are capable of activating matrix metalloproteinases types 1 and 3, causing degradation of the extracellular matrix component, collagen, necessary for the stability of the plaque. Activated mast cells also secrete matrix metalloproteinases types 1 and 9 themselves. Furthermore, chymase induces SMC apoptosis by degrading fibronectin, a pericellular matrix component necessary for SMC adhesion and survival, with the subsequent disruption of focal adhesions and loss of outside-in survival signaling. By secreting chymase and tumour necrosis factor alpha, activated mast cells also induce endothelial cell apoptosis.


CONCLUSIONS
Locally activated mast cells may participate in the weakening of atherosclerotic plaques by secreting heparin proteoglycans, chymase, and cytokines, which affect the growth, function and death of arterial endothelial cells and smooth muscle cells, thereby predisposing to plaque erosion or rupture.
Lindstedt
Ken A
KA
Wihuri Research Institute, Kalliolinnantie 4, FIN-00140 Helsinki, Finland. ken.lindstedt@wri.fi
Kovanen
Petri T
PT
D000818:Animals; D017209:Apoptosis; D001157:Arterial Occlusive Diseases / Q000473:pathology; D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation; D002633:Chemotaxis; D003094:Collagen / Q000378:metabolism; D003324:Coronary Artery Disease / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007249:Inflammation; D008407:Mast Cells / Q000166:cytology* / Q000378:metabolism; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008954:Models, Biological
D003094:Collagen; D020782:Matrix Metalloproteinases